3.30 -0.16 (-4.60%)
KERX
| Trade KERX now with |
|
Stock Details
Last Trade:3.30 Change:-0.16 (-4.60%) Prev Close:3.46 Open: 3.48 Days Range:3.25 – 3.50 52 Week Range: 2.27 - 5.55 Volume:1656270 P/E: N/AEPS:-0.38
View AllRecent Alerts 02/09/12
Recent Alert on 12/30/11 at 1:29pm
Unusual 11 Mid-Day Movers 12/30: (MOSY) (CAK) (LEAP) Higher; (DCTH) (SYMX) (LEDS) Lower
Unusual 11 Mid-Day Movers 12/30: (MOSY) (CAK) (LEAP) Higher; (DCTH) (SYMX) (LEDS) Lower
MoSys, Inc. (Nasdaq: MOSY) 43% HIGHER; MoSys and Invensas Corporation, a wholly owned subsidiary of Tessera Technologies, Inc. (Nasdaq: TSRA) entered into a patent purchase agreement. Under the agreement, Invensas purchased 43 United States and 30... Read More
Recent Alert on 12/13/11 at 8:28am
Keryx Biopharma (KERX) Reports Strong Phase 2 Data for Perifosine w/ Sorafenib in Certain HL Patients
Keryx Biopharma (KERX) Reports Strong Phase 2 Data for Perifosine w/ Sorafenib in Certain HL Patients
Recent Alert on 12/13/11 at 8:28am
Keryx Biopharma (KERX) Reports Strong Phase 2 Data for Perifosine w/ Sorafenib in Certain HL Patients
Keryx Biopharma (KERX) Reports Strong Phase 2 Data for Perifosine w/ Sorafenib in Certain HL Patients
View AllRecent Press Releases
Press Release on 02/08/12 at 8:30am
Keryx Biopharmaceuticals to Present at 14th Annual BIO CEO and Investor Conference
Keryx Biopharmaceuticals to Present at 14th Annual BIO CEO and Investor Conference